RecruitingNot ApplicableNCT06595836

Evaluation of the Performance and Acceptability of a Synthetic Polyisoprene Male Condom Compared to a Natural Rubber Latex Condom

Evaluation of the Performance and Acceptability of a Synthetic Polyisoprene Male Condom Compared to a Natural Rubber Latex Condom (Phase II Slippage/Breakage Study)


Sponsor

Thai Nippon Rubber Industry Public Company Limited

Enrollment

300 participants

Start Date

Jan 2, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study is a masked (investigators, research staff), two-way crossover, randomized to sequence of use study designed to evaluate the acceptability and functional performance (breakage, slippage) of a silicone lubricated polyisoprene condom and a silicone lubricated natural rubber latex condom.


Eligibility

Min Age: 18 YearsMax Age: 45 Years

Inclusion Criteria15

  • Between the ages of 18 and 45 (inclusive)
  • Willing and able to give written or electronic informed consent
  • Willing to respond to questions concerning their reproductive and contraceptive history and use of condoms contained either on self-administered questionnaires or interviews
  • Be sexually active (defined as averaging one vaginal coital act per week)
  • Protected against pregnancy by oral contraceptives, an IUD, an implant, contraceptive injections, contraceptive patch, or sterilization (tubal ligation or vasectomy)
  • Willing to use the study products for ten acts of vaginal intercourse within six weeks of study entry
  • In a mutually monogamous relationship with their study partner for at least 3 months and be willing to remain mutually monogamous throughout study participation
  • Agree not to use any vaginal or sexual lubricant except the product supplied by the study
  • Agree not to wear any genital piercing jewelry while using the study condoms
  • Agree not to use sex toys or drugs intended to enhance or diminish sexual response when using study condoms
  • Agree to return any unopened condoms
  • Reachable by telephone
  • Has home internet access, a valid personal email for each partner, reachable by phone, ability to videoconference and use electronic consent technology
  • Male partner agrees to ejaculate during vaginal intercourse
  • Willing to provide photo identification-

Exclusion Criteria9

  • Currently participating in another similar clinical study or employed by a condom manufacturer or Essential Access Health
  • Female partner self-reported as pregnant
  • Allergic to natural rubber latex or polyisoprene, or has a history of recurrent adverse events following use of latex or polyisoprene products
  • Unable to follow instructions or strictly adhere to the visit schedule
  • At significant (high) risk of sexually transmitted infections, including HIV infection, or having a medical history of recurrent, serious sexually transmitted infection (e.g. gonorrhea, syphilis, Chlamydia)
  • Currently using condoms for protection against a known sexually transmitted infection
  • Taking any internally applied medication or oral medication to treat a genital condition
  • Male partner has had difficulty achieving or maintaining an erection, or achieving ejaculation in the last month under typical circumstances/ conditions.
  • Any self-reported genital condition (e.g. itching, burning, irritation, etc.) which, in the opinion of the investigator, could affect use of the study condoms or the ability to interpret study data -

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICESilicone Lubricated Synthetic polyisoprine condom

Synthetic polyisoprene condom are made from softer materials for a more natural feel and increased sensitivity

DEVICESilicone Lubricated Natural Rubber Latex Condom

Natural rubber latex condoms are made from natural rubber


Locations(2)

Essential Access

Berkeley, California, United States

Essential Access

Los Angeles, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06595836


Related Trials